CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/30/2023
Back to search
Official data from USPTO
IMMUNEXPRESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNEXPRESS
ST13
US500000085051760Class
1, 5, 10, 44
Filing
85051760
Registration
4086071
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
03/30/2023
Trademark type
Word
Nice classes
1, 5, 10, 44
Filing date
06/01/2010
Registration date
01/17/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2022
Last transaction
08/08/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
11
Owner location
BOONAH, QUEENSLAND, AU
Examiner
FARRELL, ANNE
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
IMMUNEXPRESS PTY LTD
Athlomics Pty Ltd
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
biological chemical test kits for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disordersfor diagnosis and treatment of sepsis
Class 5
Diagnostic preparations for medical or veterinary use
Class 10
Surgical and medical apparatus and instruments for use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune- suppressionimmune disorders; diagnostic test apparatus for analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune- suppressionimmune disorders; diagnostic testing kits in this class consisting primarily of probesbuffers and reagents for use in microbial testing ; point of care medical devicesdevices for analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 44
Medical services; medical pathology services; medical pathology services being the analysis body fluid samples; medical services being molecular diagnostic services and taking of body fluid samples of others; providing informationadvisory and consultancy services in relation to medical services; medical pathology services; the analysis of body fluid samples; medical services being molecular diagnostic services and taking of body fluid samples of others
Publications
History of USPTO decisions and trademark events.
42 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/30/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/08/2022
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/08/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/08/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/04/2022
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
02/05/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/05/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
08/29/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/17/2021
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/28/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/29/2018
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/21/2018
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/21/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/21/2018
ES8R
TEAS SECTION 8 RECEIVED
07/17/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/17/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/17/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2011
PUBO
PUBLISHED FOR OPPOSITION
11/01/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/28/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/22/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/09/2011
GNRT
NON-FINAL ACTION E-MAILED
05/09/2011
CNRT
NON-FINAL ACTION WRITTEN
05/09/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2011
ALIE
ASSIGNED TO LIE
03/24/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2010
GNRT
NON-FINAL ACTION E-MAILED
09/16/2010
CNRT
NON-FINAL ACTION WRITTEN
09/16/2010
DOCK
ASSIGNED TO EXAMINER
09/13/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
06/05/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/04/2010
NWAP
NEW APPLICATION ENTERED
06/04/2010
Continuous trademark protection
Get notified about every new filing that threatens IMMUNEXPRESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.